Register for the upcoming 2027 Change Provider Trainings

Join our Provider Relations team members for the virtual provider collaboration session(s). Register Now

Show More

Commercial Migrated Medical Policy

View all Commercial Migrated Medical Policies ›    Learn More About Member Migration ›

Laboratory and Genetic Testing for Use of Fluoropyrimidine Chemotherapy (5-FU and Capecitabine) in Patients with Cancer

Policy ID: LAB64
Section: Laboratory
Effective Date: 3/1/2026

Download policy PDF